Dr. André Marette is a Professor of Medicine and researcher at the Heart and Lung Institute Hospital Center (IUCPQ), and at the Institute of Nutrition and Functional Foods (INAF) at Laval University. Dr. Marette holds a Valbiotis Research Chair in plant bioactives and metabolic liver diseases and a Pfizer Research Fund in the pathogenesis of insulin resistance and cardiovascular complications. He is also leading a Canadian team that is part of the Canadian Microbiome Initiative that is investigating how the microbiome is implicated in the development of type 2 diabetes.

Dr. Marette is an international renowned expert on how nutrition and the microbiome modulate immunometabolic pathways involved in obesity and cardiometabolic diseases. He is investigating the metabolic impact of nutritional interventions and microbiome-based therapeutics using both clinical and pre-clinical studies, and uses various cellular models and molecular tools to discover novel disease biomarkers and mechanistic targets. Dr. Marette’s research work has been published in over 330 papers, reviews and book chapters and he served as Editor-in-Chief for the Am J Physiol: Endo & Metab. from 2016-2022. He has also authored two books.

He has received several awards for his work including the prestigious Charles Best Award and Lectureship from the University of Toronto for his overall contribution to the advancement of scientific knowledge in the field of diabetes. He was also named member of the Belgium Royal Academy of Medicine.